Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.
Dalip Sethi, PhD, Terumo Blood and Cell Technologies
Advertisement
Commercial leader of cell therapy technologies,
North America, at Terumo Blood and Cell Technologies.
Articles by Dalip Sethi, PhD, Terumo Blood and Cell Technologies
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Merck Begins Construction on $3 Billion Pharmaceutical Center of Excellence in Virginia
2
HDA 2025 Traceability Seminar: FDA Emphasizes Readiness Over Perfection
3
